Filed: 2/14/2025ACC: 0001420506-25-000610
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 147 equity positions with a total reported market value of $735.26M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
147
Positions
$735.26M
Total AUM (reported)
60.98M
Total Shares
Allocation by class
COM$408.91M55.6%
S&P BIOTECH$130.59M17.8%
COM NEW$102.93M14.0%
CL A$36.33M4.9%
COM PAR $.01$18.63M2.5%
SPONSORED ADS$16.60M2.3%
CL A NEW$7.56M1.0%
Portfolio Concentration
Top 3$200.42M27.3%
4–10$138.61M18.9%
11–25$152.41M20.7%
Rest$243.81M33.2%
Top 3 weight
27.3%
Top 10 weight
46.1%
Voting Authority Distribution
Total shares with voting rights: 60.98M
Sole
Full voting authority
60.98M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole147
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings147
Rows:
SPDR SER TR
SOLEShares1.45M
TypeSH
Market value$130.59M
17.76%
Sole
1.45M
Shared
0.00
None
0.00
TYSON FOODS INC
SOLEShares630K
TypeSH
Market value$36.19M
4.92%
Sole
630K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares607.69K
TypeSH
Market value$33.65M
4.58%
Sole
607.69K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares516.43K
TypeSH
Market value$26.41M
3.59%
Sole
516.43K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares915.71K
TypeSH
Market value$25.13M
3.42%
Sole
915.71K
Shared
0.00
None
0.00
SCHOLAR ROCK HLDG CORP
SOLEShares459.29K
TypeSH
Market value$19.85M
2.70%
Sole
459.29K
Shared
0.00
None
0.00
AMGEN INC
SOLEShares74K
TypeSH
Market value$19.29M
2.62%
Sole
74K
Shared
0.00
None
0.00
INSMED INC
SOLEShares269.80K
TypeSH
Market value$18.63M
2.53%
Sole
269.80K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares169.37K
TypeSH
Market value$14.77M
2.01%
Sole
169.37K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares500K
TypeSH
Market value$14.54M
1.98%
Sole
500K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares115.09K
TypeSH
Market value$13.99M
1.90%
Sole
115.09K
Shared
0.00
None
0.00
FORTE BIOSCIENCES INC
SOLEShares609.23K
TypeSH
Market value$13.84M
1.88%
Sole
609.23K
Shared
0.00
None
0.00
PILGRIMS PRIDE CORP
SOLEShares300K
TypeSH
Market value$13.62M
1.85%
Sole
300K
Shared
0.00
None
0.00
NEUMORA THERAPEUTICS INC.
SOLEShares1.25M
TypeSH
Market value$13.25M
1.80%
Sole
1.25M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares645.05K
TypeSH
Market value$12.37M
1.68%
Sole
645.05K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares1.62M
TypeSH
Market value$11.88M
1.62%
Sole
1.62M
Shared
0.00
None
0.00
CAPRICOR THERAPEUTICS INC
SOLEShares661.10K
TypeSH
Market value$9.12M
1.24%
Sole
661.10K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares394.54K
TypeSH
Market value$8.88M
1.21%
Sole
394.54K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares291.24K
TypeSH
Market value$8.77M
1.19%
Sole
291.24K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$8.46M
1.15%
Sole
100K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares519.36K
TypeSH
Market value$7.73M
1.05%
Sole
519.36K
Shared
0.00
None
0.00
CAL MAINE FOODS INC
SOLEShares75K
TypeSH
Market value$7.72M
1.05%
Sole
75K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares284.08K
TypeSH
Market value$7.70M
1.05%
Sole
284.08K
Shared
0.00
None
0.00
GINKGO BIOWORKS HOLDINGS INC
SOLEShares769.70K
TypeSH
Market value$7.56M
1.03%
Sole
769.70K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares178.99K
TypeSH
Market value$7.53M
1.02%
Sole
178.99K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 1.45M | SH | $130.59M 17.76% | 1.45M | 0.00 | 0.00 |
TYSON FOODS INCSOLE | CL A | 630K | SH | $36.19M 4.92% | 630K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 607.69K | SH | $33.65M 4.58% | 607.69K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 516.43K | SH | $26.41M 3.59% | 516.43K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 915.71K | SH | $25.13M 3.42% | 915.71K | 0.00 | 0.00 |
SCHOLAR ROCK HLDG CORPSOLE | COM | 459.29K | SH | $19.85M 2.70% | 459.29K | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 74K | SH | $19.29M 2.62% | 74K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 269.80K | SH | $18.63M 2.53% | 269.80K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 169.37K | SH | $14.77M 2.01% | 169.37K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 500K | SH | $14.54M 1.98% | 500K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 115.09K | SH | $13.99M 1.90% | 115.09K | 0.00 | 0.00 |
FORTE BIOSCIENCES INCSOLE | COM NEW | 609.23K | SH | $13.84M 1.88% | 609.23K | 0.00 | 0.00 |
PILGRIMS PRIDE CORPSOLE | COM | 300K | SH | $13.62M 1.85% | 300K | 0.00 | 0.00 |
NEUMORA THERAPEUTICS INC.SOLE | COM | 1.25M | SH | $13.25M 1.80% | 1.25M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 645.05K | SH | $12.37M 1.68% | 645.05K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 1.62M | SH | $11.88M 1.62% | 1.62M | 0.00 | 0.00 |
CAPRICOR THERAPEUTICS INCSOLE | COM NEW | 661.10K | SH | $9.12M 1.24% | 661.10K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 394.54K | SH | $8.88M 1.21% | 394.54K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 291.24K | SH | $8.77M 1.19% | 291.24K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 100K | SH | $8.46M 1.15% | 100K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 519.36K | SH | $7.73M 1.05% | 519.36K | 0.00 | 0.00 |
CAL MAINE FOODS INCSOLE | COM NEW | 75K | SH | $7.72M 1.05% | 75K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 284.08K | SH | $7.70M 1.05% | 284.08K | 0.00 | 0.00 |
GINKGO BIOWORKS HOLDINGS INCSOLE | CL A NEW | 769.70K | SH | $7.56M 1.03% | 769.70K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 178.99K | SH | $7.53M 1.02% | 178.99K | 0.00 | 0.00 |
Page 1 of 6
…